These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11566008)

  • 1. IS-741 (Ishihara Sangyo).
    Bassi C
    Curr Opin Investig Drugs; 2001 Apr; 2(4):510-2. PubMed ID: 11566008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antipancreatitis activities of novel N-(2-sulfonylamino-5-trifluoromethyl-3-pyridyl)carboxamide derivatives as phospholipase A2 inhibitors.
    Kimura H; Yotsuya S; Yuki S; Sugi H; Shigehara I; Haga T
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1696-700. PubMed ID: 8536343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of a novel phospholipase A2 inhibitor in acute pancreatitis.
    Uhl W; Schrag HJ; Schmitter N; Aufenanger J; Nevalainen TJ; Büchler MW
    Br J Surg; 1998 May; 85(5):618-23. PubMed ID: 9635806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a new inhibitor of type II phospholipase A2 on experimental acute pancreatitis in rats.
    Yoshikawa T; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Ono T; Hayakawa T
    Pancreas; 1999 Aug; 19(2):193-8. PubMed ID: 10438167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blind study using CaNa2EDTA, a phospholipase A2 inhibitor, in the management of human acute pancreatitis.
    Tykkä HT; Vaittinen EJ; Mahlberg KL; Railo JE; Pantzar PJ; Sarna S; Tallberg T
    Scand J Gastroenterol; 1985 Jan; 20(1):5-12. PubMed ID: 3922048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
    Kahle M; Klein U; König W; Martin U; Alles JU
    Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro.
    Mäkelä A; Kuusi T; Schröder T
    Scand J Clin Lab Invest; 1997 Aug; 57(5):401-7. PubMed ID: 9279965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase A2 inhibitors and their possible clinical use in the treatment of acute pancreatitis.
    Tykkä H; Mahlberg K; Pantzar P; Tallberg T
    Scand J Gastroenterol; 1980; 15(5):519-28. PubMed ID: 6777862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phospholipase A2 in acute pancreatitis.
    Nevalainen TJ
    Z Med Lab Diagn; 1989; 30(6):299-303. PubMed ID: 2683447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
    Kahle M; König H; Filler RD
    Klin Wochenschr; 1989 Feb; 67(3):177-9. PubMed ID: 2494378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
    Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural product derived inhibitors of lipoprotein associated phospholipase A2, synthesis and activity of analogues of SB-253514.
    Pinto IL; Boyd HF; Hickey DM
    Bioorg Med Chem Lett; 2000 Sep; 10(17):2015-7. PubMed ID: 10987439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IS-741 (a new synthetic antiinflammatory agent) on acute necrotizing pancreatitis in dogs. Significance of its inhibitory effect on cytosolic phospholipase A2.
    Isaji S; Hayashi J; Higashiguchi T; Yokoi H; Ogura Y; Noguchi T; Kawarada Y
    Digestion; 1999; 60 Suppl 1():47-51. PubMed ID: 10026431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.
    Stephens D; Barbayianni E; Constantinou-Kokotou V; Peristeraki A; Six DA; Cooper J; Harkewicz R; Deems RA; Dennis EA; Kokotos G
    J Med Chem; 2006 May; 49(9):2821-8. PubMed ID: 16640343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of lipophilic keto acids by acylation of alkylbenzenes as potential inhibitors of phospholipase A2].
    Nuhn P; Radman M; Hermann A; Marx K
    Pharmazie; 1998 Dec; 53(12):825-9. PubMed ID: 10189306
    [No Abstract]   [Full Text] [Related]  

  • 17. Current aspects of the pathophysiology of acute pancreatitis and therapeutic effects of an inflammatory cell infiltration inhibitor.
    Manabe T
    J Gastroenterol; 2003; 38(3):305-7. PubMed ID: 12693385
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipidic mimetics as inhibitors of pancreatic phospholipase A2.
    Nicolaou A; Kokotos G; Constantinou V; York J; Gibbons WA
    Biochem Soc Trans; 1995 Nov; 23(4):614S. PubMed ID: 8654799
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new pathophysiologic concept in chronic pancreatitis: tissue destruction induced via inflammatory mediators].
    Friess H; Kashiwagi M; Uhl W; Schilling M; Zimmermann A; Büchler MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):431-6. PubMed ID: 14518291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorpromazine treatment of experimental acute fulminant pancreatitis in pigs.
    Schröder T; Lempinen M; Nordling S; Kinnunen PK
    Eur Surg Res; 1981; 13(2):143-51. PubMed ID: 7297579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.